These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32885397)

  • 1. Quality Tolerance Limits: Framework for Successful Implementation in Clinical Development.
    Bhagat R; Bojarski L; Chevalier S; Görtz DR; Le Meignen S; Makowski M; Nadolny P; Pillwein M; Suprin M; Turri S
    Ther Innov Regul Sci; 2021 Mar; 55(2):251-261. PubMed ID: 32885397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Council for Harmonisation E6(R2) addendum: Challenges of implementation.
    Bhatt A
    Perspect Clin Res; 2017; 8(4):162-166. PubMed ID: 29109932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality Tolerance Limits' Place in the Quality Management System and Link to the Statistical Trial Design: Case Studies and Recommendations from Early Adopters.
    Wolfs M; Bojarski Ł; Young S; Cesario L; Makowski M; Sullivan LB
    Ther Innov Regul Sci; 2023 Jul; 57(4):839-848. PubMed ID: 36972010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stakeholders' views on the most and least helpful aspects of the ICH E6 GCP guideline and their aspirations for the revision of ICH E6(R2).
    Dombeck C; Swezey T; Forrest A; Tenaerts P; Corneli A
    Contemp Clin Trials Commun; 2022 Oct; 29():100983. PubMed ID: 36111176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality Risk Management Framework: Guidance for Successful Implementation of Risk Management in Clinical Development.
    Suprin M; Chow A; Pillwein M; Rowe J; Ryan M; Rygiel-Zbikowska B; Wilson KJ; Tomlin I
    Ther Innov Regul Sci; 2019 Jan; 53(1):36-44. PubMed ID: 30789098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TransCelerate's Clinical Quality Management System: From a Vision to a Conceptual Framework.
    Meeker-O'Connell A; Sam LM; Bergamo N; Little JA
    Ther Innov Regul Sci; 2016 Jul; 50(4):397-413. PubMed ID: 30227025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Historical Benchmarks for Quality Tolerance Limits Parameters in Clinical Trials.
    Makowski M; Bhagat R; Chevalier S; Gilbert SA; Görtz DR; Kozińska M; Nadolny P; Suprin M; Turri S
    Ther Innov Regul Sci; 2021 Nov; 55(6):1265-1273. PubMed ID: 34453269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enabling ICH Q10 Implementation--Part 1. Striving for Excellence by Embracing ICH Q8 and ICH Q9.
    Calnan N; O'Donnell K; Greene A
    PDA J Pharm Sci Technol; 2013; 67(6):581-600. PubMed ID: 24265300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?: Insights and Perspectives From the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) Addendum.
    Morga A; Latimer NR; Scott M; Hawkins N; Schlichting M; Wang J
    Value Health; 2023 Feb; 26(2):234-242. PubMed ID: 36150999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A note on the draft International Council for Harmonisation guidance on estimands and sensitivity analysis.
    Mehrotra DV
    Clin Trials; 2019 Aug; 16(4):339-344. PubMed ID: 30977390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stakeholders' recommendations for revising Good Clinical Practice.
    Corneli A; Forrest A; Swezey T; Lin L; Tenaerts P
    Contemp Clin Trials Commun; 2021 Jun; 22():100776. PubMed ID: 33997463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Process Management Framework: Guidance to Successful Implementation of Processes in Clinical Development.
    Husovich ME; Zadro R; Zoller-Neuner LL; Vangheel G; Anyangwe O; Ryan DP; Rygiel-Zbikowska B
    Ther Innov Regul Sci; 2019 Jan; 53(1):25-35. PubMed ID: 30789099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toolkit for ICH E6 (R2) Quality Risk Management for Small to Medium Size Companies.
    Della-Coletta A; Katz T; Kupka K; Mohan S; Novak KA; Petrizzo M; Silvers SA
    Ther Innov Regul Sci; 2020 Jul; 54(4):900-921. PubMed ID: 32557313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing Quality and Efficiency in Clinical Development Through a Clinical QMS Conceptual Framework: Concept Paper Vision and Outline.
    Meeker-O'Connell A; Borda MM; Little JA; Sam LM
    Ther Innov Regul Sci; 2015 Sep; 49(5):615-622. PubMed ID: 30227039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimands in practice: Bridging the gap between study objectives and statistical analysis.
    Phillips A; Clark T
    Pharm Stat; 2021 Jan; 20(1):68-76. PubMed ID: 32893473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ISO 9001:2015 Versus ICH Q10 - A Comparison.
    Aaberg C; Dahmen H; Davies C; Sandau PL; Srinivasan R
    PDA J Pharm Sci Technol; 2021; 75(2):188-206. PubMed ID: 32999074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2C(R2) Periodic Benefit-Risk Evaluation Report and E2C(R2) Periodic Benefit-Risk Evaluation Report--Questions and Answers; International Council for Harmonisation; Guidances for Industry; Availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2016 Jul; 81(138):46938-40. PubMed ID: 27459749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead.
    Shah RR
    Drug Saf; 2005; 28(11):1009-28. PubMed ID: 16231954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Conference on Harmonisation; addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 May; 77(97):29665-6. PubMed ID: 22616137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General Principles for the Education and Training of GCP Inspectors: The Outcome of Discussions by International Regulatory Experts in the Discussion Group on the ICH E6 Guideline.
    Uyama Y; Yamazaki E; Clark K; Wang CY; Woro E; Tong FY; Sachidanandan S; Rodriguez A; Oh H; Saleh K; Cirunay J; Wapeewuttikorn A; Rogov E; Alshahwan KW; Herrera I; Mthetwa J; Fakudze F; Osawa T
    Ther Innov Regul Sci; 2015 Mar; 49(2):249-253. PubMed ID: 30222411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.